North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer

Standard

North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer. / Leyh-Bannurah, Sami-Ramzi; Budäus, Lars; Pompe, Raisa; Zaffuto, Emanuele; Briganti, Alberto; Abdollah, Firas; Montorsi, Francesco; Schiffmann, Jonas; Menon, Mani; Shariat, Shahrokh F; Fisch, Margit; Chun, Felix; Huland, Hartwig; Graefen, Markus; Karakiewicz, Pierre I.

In: PROSTATE, Vol. 77, No. 5, 04.2017, p. 542-548.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Leyh-Bannurah, S-R, Budäus, L, Pompe, R, Zaffuto, E, Briganti, A, Abdollah, F, Montorsi, F, Schiffmann, J, Menon, M, Shariat, SF, Fisch, M, Chun, F, Huland, H, Graefen, M & Karakiewicz, PI 2017, 'North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer', PROSTATE, vol. 77, no. 5, pp. 542-548. https://doi.org/10.1002/pros.23292

APA

Leyh-Bannurah, S-R., Budäus, L., Pompe, R., Zaffuto, E., Briganti, A., Abdollah, F., Montorsi, F., Schiffmann, J., Menon, M., Shariat, S. F., Fisch, M., Chun, F., Huland, H., Graefen, M., & Karakiewicz, P. I. (2017). North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer. PROSTATE, 77(5), 542-548. https://doi.org/10.1002/pros.23292

Vancouver

Bibtex

@article{3558b16051254825976ca9dd969c7132,
title = "North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer",
abstract = "BACKGROUND: National Comprehensive Cancer Network (NCCN) guidelines recommend a pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients treated with radical prostatectomy (RP) if a nomogram predicted risk of lymph node invasion (LNI) is ≥2%. We examined this and other thresholds, including nomogram validation.METHODS: We examined records of 26,713 patients treated with RP and PLND between 2010 and 2013, within the Surveillance, Epidemiology, and End Results database. Nomogram thresholds of 2-5% were tested and external validation was performed.RESULTS: LNI was recorded in 4.7% of patients. Nomogram accuracy was 80.4% and maintained minimum accuracy of 75.6% in subgroup analyses, according to age, race, and nodal yield >10. With the NCCN recommended 2% nomogram threshold, PLND could be avoided in 22.3% of patients at the expense of missing 3.0% of individuals with LNI. Alternative thresholds of 3%, 4%, and 5% yielded respective PLND avoidance rates of 60.4%, 71.0%, and 79.8% at the expense of missing 17.8%, 27.2%, and 36.6% of patients with LNI. NCCN cut-off recommendation was best satisfied with a threshold of <2.6%, at which PLND could be avoided in 13,234 patients (49.5%) versus missing 141 patients with LNI (11.2%).CONCLUSION: NCCN LNI nomogram remains accurate in contemporary patients. However, the 2% threshold appears to be too strict, since only 22.3% of PLNDs can be avoided, instead of the stipulated 47.7%. The optimal 2.6% threshold allows a higher rate of PLND avoidance (49.5%), at the cost of 11.2% missed instances of LNI, as recommended by NCCN guidelines. PATIENT SUMMARY. External validation in contemporary SEER prostate cancer patients showed that the NCCN nomogram remains accurate for predicting lymph node invasion and seems to be optimal at an alternative 2.6% threshold, with best ratio of avoided pelvic lymph node dissections (49.5%) and missed LNIs (11.2%), as recommended by NCCN guideline. Prostate 77:542-548, 2017. {\textcopyright} 2017 Wiley Periodicals, Inc.",
keywords = "Aged, Databases, Factual, Humans, Information Services, Lymph Node Excision, Male, Middle Aged, Nomograms, North America, Pelvis, Population Surveillance, Practice Guidelines as Topic, Prostatectomy, Prostatic Neoplasms, Registries, United States, Journal Article, Validation Studies",
author = "Sami-Ramzi Leyh-Bannurah and Lars Bud{\"a}us and Raisa Pompe and Emanuele Zaffuto and Alberto Briganti and Firas Abdollah and Francesco Montorsi and Jonas Schiffmann and Mani Menon and Shariat, {Shahrokh F} and Margit Fisch and Felix Chun and Hartwig Huland and Markus Graefen and Karakiewicz, {Pierre I}",
note = "{\textcopyright} 2017 Wiley Periodicals, Inc.",
year = "2017",
month = apr,
doi = "10.1002/pros.23292",
language = "English",
volume = "77",
pages = "542--548",
journal = "PROSTATE",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer

AU - Leyh-Bannurah, Sami-Ramzi

AU - Budäus, Lars

AU - Pompe, Raisa

AU - Zaffuto, Emanuele

AU - Briganti, Alberto

AU - Abdollah, Firas

AU - Montorsi, Francesco

AU - Schiffmann, Jonas

AU - Menon, Mani

AU - Shariat, Shahrokh F

AU - Fisch, Margit

AU - Chun, Felix

AU - Huland, Hartwig

AU - Graefen, Markus

AU - Karakiewicz, Pierre I

N1 - © 2017 Wiley Periodicals, Inc.

PY - 2017/4

Y1 - 2017/4

N2 - BACKGROUND: National Comprehensive Cancer Network (NCCN) guidelines recommend a pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients treated with radical prostatectomy (RP) if a nomogram predicted risk of lymph node invasion (LNI) is ≥2%. We examined this and other thresholds, including nomogram validation.METHODS: We examined records of 26,713 patients treated with RP and PLND between 2010 and 2013, within the Surveillance, Epidemiology, and End Results database. Nomogram thresholds of 2-5% were tested and external validation was performed.RESULTS: LNI was recorded in 4.7% of patients. Nomogram accuracy was 80.4% and maintained minimum accuracy of 75.6% in subgroup analyses, according to age, race, and nodal yield >10. With the NCCN recommended 2% nomogram threshold, PLND could be avoided in 22.3% of patients at the expense of missing 3.0% of individuals with LNI. Alternative thresholds of 3%, 4%, and 5% yielded respective PLND avoidance rates of 60.4%, 71.0%, and 79.8% at the expense of missing 17.8%, 27.2%, and 36.6% of patients with LNI. NCCN cut-off recommendation was best satisfied with a threshold of <2.6%, at which PLND could be avoided in 13,234 patients (49.5%) versus missing 141 patients with LNI (11.2%).CONCLUSION: NCCN LNI nomogram remains accurate in contemporary patients. However, the 2% threshold appears to be too strict, since only 22.3% of PLNDs can be avoided, instead of the stipulated 47.7%. The optimal 2.6% threshold allows a higher rate of PLND avoidance (49.5%), at the cost of 11.2% missed instances of LNI, as recommended by NCCN guidelines. PATIENT SUMMARY. External validation in contemporary SEER prostate cancer patients showed that the NCCN nomogram remains accurate for predicting lymph node invasion and seems to be optimal at an alternative 2.6% threshold, with best ratio of avoided pelvic lymph node dissections (49.5%) and missed LNIs (11.2%), as recommended by NCCN guideline. Prostate 77:542-548, 2017. © 2017 Wiley Periodicals, Inc.

AB - BACKGROUND: National Comprehensive Cancer Network (NCCN) guidelines recommend a pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients treated with radical prostatectomy (RP) if a nomogram predicted risk of lymph node invasion (LNI) is ≥2%. We examined this and other thresholds, including nomogram validation.METHODS: We examined records of 26,713 patients treated with RP and PLND between 2010 and 2013, within the Surveillance, Epidemiology, and End Results database. Nomogram thresholds of 2-5% were tested and external validation was performed.RESULTS: LNI was recorded in 4.7% of patients. Nomogram accuracy was 80.4% and maintained minimum accuracy of 75.6% in subgroup analyses, according to age, race, and nodal yield >10. With the NCCN recommended 2% nomogram threshold, PLND could be avoided in 22.3% of patients at the expense of missing 3.0% of individuals with LNI. Alternative thresholds of 3%, 4%, and 5% yielded respective PLND avoidance rates of 60.4%, 71.0%, and 79.8% at the expense of missing 17.8%, 27.2%, and 36.6% of patients with LNI. NCCN cut-off recommendation was best satisfied with a threshold of <2.6%, at which PLND could be avoided in 13,234 patients (49.5%) versus missing 141 patients with LNI (11.2%).CONCLUSION: NCCN LNI nomogram remains accurate in contemporary patients. However, the 2% threshold appears to be too strict, since only 22.3% of PLNDs can be avoided, instead of the stipulated 47.7%. The optimal 2.6% threshold allows a higher rate of PLND avoidance (49.5%), at the cost of 11.2% missed instances of LNI, as recommended by NCCN guidelines. PATIENT SUMMARY. External validation in contemporary SEER prostate cancer patients showed that the NCCN nomogram remains accurate for predicting lymph node invasion and seems to be optimal at an alternative 2.6% threshold, with best ratio of avoided pelvic lymph node dissections (49.5%) and missed LNIs (11.2%), as recommended by NCCN guideline. Prostate 77:542-548, 2017. © 2017 Wiley Periodicals, Inc.

KW - Aged

KW - Databases, Factual

KW - Humans

KW - Information Services

KW - Lymph Node Excision

KW - Male

KW - Middle Aged

KW - Nomograms

KW - North America

KW - Pelvis

KW - Population Surveillance

KW - Practice Guidelines as Topic

KW - Prostatectomy

KW - Prostatic Neoplasms

KW - Registries

KW - United States

KW - Journal Article

KW - Validation Studies

U2 - 10.1002/pros.23292

DO - 10.1002/pros.23292

M3 - SCORING: Journal article

C2 - 28093788

VL - 77

SP - 542

EP - 548

JO - PROSTATE

JF - PROSTATE

SN - 0270-4137

IS - 5

ER -